Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02626208 · ClinicalTrials.gov registry record · Phase 2
Dose Finding Study of Contraceptive Vaginal Ring With Different Estradiol Levels in Combination With Nestorone
A Phase 2 study, sponsored by Premier Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT02626208 is a Phase 2 study that has completed, run by Premier Research. The registered enrollment target is 65 participants.
The verdict
NCT02626208, a Phase 2 study, has completed, sponsored by Premier Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
This clinical trial investigates a new vaginal delivery system made of silicone rubber, containing Nestorone®, a 19-nor progesterone derivative and a low dose of serum estradiol (E2). The investigators plan to evaluate one-month data on the serum estradiol (E2) levels of three different contraceptive vaginal rings that contain a fixed dose of NES and escalating doses (75 µg/day, 100 µg/day, or 200 µg/day) of estradiol as the basis for selecting a CVR for a larger contraceptive efficacy trial.
Interventions
- DEVICE Nestorone®/Estradiol Contraceptive Vaginal Ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02626208
The ClinicalTrials.gov registry entry for NCT02626208 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Premier Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nestorone®/Estradiol Contraceptive Vaginal Ring is the first listed.
NCT02626208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02626208 about?
NCT02626208 is a clinical study titled "Dose Finding Study of Contraceptive Vaginal Ring With Different Estradiol Levels in Combination With Nestorone". This clinical trial investigates a new vaginal delivery system made of silicone rubber, containing Nestorone®, a 19-nor progesterone derivative and a low dose of serum estradiol (E2). The investigators plan to evaluate one-month data on the serum estradiol (E2) levels of three different contraceptiv...
What is the current status of trial NCT02626208?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2016-01. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02626208?
The interventions under investigation include: Nestorone®/Estradiol Contraceptive Vaginal Ring (DEVICE).
Who is sponsoring clinical trial NCT02626208?
This trial is sponsored by Premier Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.